Posts Tagged ‘startup’
10th Patient Quality of Life Challenge: Five Innovative Projects Awarded
For its 10th edition, the Patient Quality of Life Challenge reaffirmed its role as a launch pad for innovation in healthcare. Five finalists were selected out of more than 150 applications. Driven by Debiopharm, La-Solution.ch, and the Inartis Foundation, the Patient Quality of Life Challenge attracted nearly 150 submissions this year. Five finalists were…
Read MoreMyriad Optics Raises CHF 150’000 from Venture Kick
The EPFL spin-off develops new and disruptive bacterial contamination detection tools that can revolutionize food testing. Testing delays lasting hours to days cost companies millions and expose consumers to health risks. Myriad Optics’ technology targets faster detection to prevent costly recalls and protect public safety. In the food, pharma, and medtech sectors, delays in…
Read MoreClee Medical Wins a W.A. De Vigier Award
Clee Medical, a Wyss Center for Bio and Neuroengineering Geneva spinoff, wins a W.A. De Vigier Award worth CHF 120’000 Clee Medical, a Geneva-based medtech startup, is transforming brain surgery with an advanced platform that combines ultra-high-resolution real-time imaging, AI-based navigation, and machine learning. This technology allows surgeons to operate with extreme precision, reducing…
Read MoreOdne, an EPFL and ETHZ spinoff, raises CHF 4,2 Million in Series A
Odne’s story began through a close collaboration between leading researchers at EPFL and ETHZ, who sought to address long-standing clinical challenges in endodontic therapy. With over CHF 4.2 million raised in its Series A1 round — including support from ZEISS Ventures — and several FDA-cleared products now entering the U.S. market, the medtech company is…
Read MoreAzureCell Therapies Secures Innosuisse Grant to Advance Parkinson Disease Treatment
AzureCell Therapies, a University of Geneva spinoff at the forefront of regenerative medicine, has been awarded a CHF 650,000 grant from Innosuisse, Switzerland’s innovation agency, to advance its pioneering cell-replacement therapies for Parkinson’s disease. Rooted in over 20 years of research from the University of Geneva and backed by over CHF 8 million in…
Read MoreAtinary Technologies Gets Funding to Accelerate Antibiotics Discovery with AI
Atinary Technologies, a pioneering Swiss deeptech startup, has announced its participation in a groundbreaking project funded by AIchemy, a UK-based initiative supported by the Engineering and Physical Sciences Research Council. In partnership with the Frei Lab at the University of York, Atinary is set to transform antibiotic discovery by focusing on a promising yet underexplored…
Read MoreSwiss Health Valley Startups Shine at Major Pitching Events
The Swiss Health Valley continues to be a powerhouse of innovation, as multiple startups made their mark at major pitching events across Europe. These groundbreaking companies are not only transforming health and wellness but also bringing international recognition to the region. At Start Contest 2024-2025, PMAX Labs emerged as the grand prize winner…
Read MoreTOP 100 Swiss Startup Award: Vote Now!
The TOP 100 Swiss Startup Award is back! Vote until 20 July 2025 for your favourite Life Sciences start-up. Every year, the TOP 100 Swiss Startup Award showcases the 100 most innovative and promising Swiss startups chosen by a 100-strong jury of leading investors and experts. The TOP 100 Public Vote runs parallel to the expert jury…
Read MoreBioscibex, Inkocell Therapeutics, and OrthoSens Supported By Venture Kick
Bioscibex, Inkocell Therapeutics, and OrthoSens were selected at Venture Kick’s second financial and entrepreneurial support stage and get each a CHF 40’000 support. These three Swiss Health Valley startups reshape biopharma, oncology, and orthopedic recovery. Bioscibex, Inkocell Therapeutics, and OrthoSens have progressed to the second stage of Venture Kick, securing support to drive their innovations…
Read MoreAerospec, Carewell, OptiZone and SaisiR Finalists of the PERL Prize
Four Swiss Health Valley start-ups selected from the 5 finalists in the 23rd Prix Entreprendre Lausanne Région (PERL): Aerospec, Carewell, OptiZone and SaisiR. Nearly 60 companies from the Lausanne region applied for the PERL 2025 awards. Only five have been selected for the Awards Ceremony, to be held on Wednesday 7 May, and only one…
Read More